top of page

Contact

Thank you for your submission!

Organisation

Board

The Foundation does not pay per-meeting fees or additional compensation to the chair or other selected board members.

Prof Gerrit van Meer (chair) Mr. Hugo Hooft Graafland (treasurer) Prof Karin Fijnvandraat (secretary) drs Annemarie Haverhals (board member) Prof Koen Mertens (board member and liaison officer to the Scientific Advisory Council)

Prof. Karin Fijnvandraat

First term ends June 2027

Secretary

Prof Gerrit van Meer (chair) Mr. Hugo Hooft Graafland (treasurer) Prof Karin Fijnvandraat (secretary) drs Annemarie Haverhals (board member) Prof Koen Mertens (board member and liaison officer to the Scientific Advisory Council)

Prof. Koen Mertens

Second term ends June 2028

Board Member & Liaison Officer

Prof Gerrit van Meer (chair) Mr. Hugo Hooft Graafland (treasurer) Prof Karin Fijnvandraat (secretary) drs Annemarie Haverhals (board member) Prof Koen Mertens (board member and liaison officer to the Scientific Advisory Council)

Drs. Annemarie Haverhals

Second term ends June 2027

Board Member

Prof Gerrit van Meer (chair) Mr. Hugo Hooft Graafland (treasurer) Prof Karin Fijnvandraat (secretary) drs Annemarie Haverhals (board member) Prof Koen Mertens (board member and liaison officer to the Scientific Advisory Council)

Mr. Eugène van Nispen tot Sevenaer

First term ends June 2029

Treasurer

Prof Gerrit van Meer (chair) Mr. Hugo Hooft Graafland (treasurer) Prof Karin Fijnvandraat (secretary) drs Annemarie Haverhals (board member) Prof Koen Mertens (board member and liaison officer to the Scientific Advisory Council)

Prof. Gerrit van Meer

First term ends June 2024

Chair

Scientific Advisory Council

The Foundation does not pay per-meeting fees or additional compensation to the chair or other selected council members.

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Prof. Jeroen Eikenboom

Department of Haematology, Leiden University Medical Center

Chair

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Prof. Masja de Haas

Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Prof. Marie Cully

Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Dr. Carlijn Voermans

Laboratory for Cell Therapy, Sanquin Research

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Prof. Eric Eldering

Dept. Experimental Immunology, Amsterdam University Medical Center

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Prof. Elisa Laurenti

Department of Haematology, University of Cambridge, UK
Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Dr. Cedric Ghevaert

Cambridge Stem Cell Institute, University of Cambridge, UK

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Prof. Kathleen Freson

Centre for Molecular and Vascular Biology, University Leuven, Belgium

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Associate Prof. Ramon Arens

Department of Immunology, Leiden University Medical Center

Scientific Advisory Council

Associate Prof Ramon Arens, Department of Immunology, Leiden University Medical Center Prof Marie Cully, Immune Thrombocytopenic Purpura (ITP) Clinic, University College London, UK Prof Jeroen Eikenboom (chair), Department of Haematology, Leiden University Medical Center Prof Eric Eldering, Dept. Experimental Immunology, Amsterdam University Medical Center Prof Kathleen Freson, Centre for Molecular and Vascular Biology, University Leuven, Belgium Dr Cedric Ghevaert, Cambridge Stem Cell Institute, University of Cambridge, UK Prof Masja de Haas, Translational Immunohaematology, Sanquin Research, Amsterdam and Consultant Immunohaematology, Leiden University Medical Center Prof Elisa Laurenti, Department of Haematology, University of Cambridge, UK Associate Prof Rolf Urbanus, Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center Dr Carlijn Voermans, Laboratory for Cell Therapy, Sanquin Research, Amsterdam

Associate Prof. Rolf Urbanus

Division Internal Medicine and Dermatology, Van Creveldclinic, Utrecht University Medical Center

Scientific Advisory Council

Office of the LSBR

Brigitte Voogt, QT (financial controller) drs Bart Kranenburg (executive secretary) Rogier van den Braak, RA (director)

Drs. Bart Kranenburg

Executive Secretary

Brigitte Voogt, QT (financial controller) drs Bart Kranenburg (executive secretary) Rogier van den Braak, RA (director)

Drs. Brigitte Voogt

Financial Controller

Brigitte Voogt, QT (financial controller) drs Bart Kranenburg (executive secretary) Rogier van den Braak, RA (director)

Rogier van den Braak, RA

Director

bottom of page